Tetlow joins Pathwork as CFO
Thursday, November 3, 2011
Pathwork Diagnostics has named Sharon Tetlow chief financial officer.
Tetlow has over a dozen years of experience as CFO in life sciences and a strong track record of strategic execution and capital raising. She was most recently senior vice president and CFO of Cell Genesys, a publicly traded biotechnology company.
“We are delighted to welcome Ms. Tetlow to the Pathwork team,” said Deborah Neff, chief executive officer of Pathwork. “Sharon’s considerable experience as CFO in both public and private companies will be invaluable as we execute our strategy to create and commercialize high value molecular diagnostics to help guide cancer treatment.”